Table 2.
Percentages of participants experiencing specific adverse events.
| Symptom | TBS (n = 76) | Sp/ppTMS (n = 89) |
|---|---|---|
| Headache | 6.6% | 6.7% |
| Scalp pain | – | 4.5% |
| Arm/hand/other pain | 2.6%* | 2.2% |
| Numbness/tingling | 2.6% | 5.6% |
| Other sensations | 2.6% | 1.1%** |
| Weakness | 1.3% | – |
| Ringing in ears | – | 1.1%* |
| Nausea/vomiting | – | 1.1% |
| Other | 1.3% | 1.1% |
All adverse events were rated minimal to mild except: *one subject each rated “moderate”; **one subject rated “marked”. “Other sensations**” referred to chest pain that was present at baseline due to one subject having an upper respiratory infection at the time of the visit. The “ringing in ears*” and “other sensations**” ratings were from the same individual within one sp/ppTMS session. TBS = Theta Burst Stimulation, Sp/ppTMS = single and paired pulse transcranial magnetic stimulation.